Allowing Americans aged 50 to 64 to buy into Medicare would lower health care premiums for the group. But it would also drive up costs for younger people who buy health insurance on Affordable Care Act exchanges.
Medicare appears to be overpaying surgeons for many medical procedures. Federal officials should incorporate ways to more objectively measure the amount of postoperative care surgeons provide to patients.
States participating in Project JOINTS, a six-month quality improvement campaign to reduce infection risk after joint replacement surgery, adhered to three new evidence-based practices significantly more than non-participants.
This report presents results of the first Alpha 1 feasibility test of proposed items to include in the post-acute care patient assessment instruments for measuring seven areas of health status for Medicare beneficiaries.
The Medicare Access and Chip Reauthorization Act (MACRA) will decrease Medicare spending on physician services by an estimated -$35 to -$106 billion and change spending on hospital services by +$32 to -$250 billion between 2015 and 2030.
This report summarizes RAND's pilot testing of a set of proposed nonpayment codes that physicians would use for post-operative visits. The goal of testing was to assess whether practitioners understood and could correctly apply the codes.
Starting in 2019, the Medicare Access and CHIP Reauthorization Act will integrate and potentially simplify performance measurement by combining many measures and programs. Research provides insight into how to avoid pitfalls in MACRA's rollout.
To inform the debate in the New Jersey state legislature, this report analyzes the role of payments for involuntary out-of-network care for New Jersey hospitals' financial performance and simulates the effect of policies to limit such payments.
Hospitals face penalties for excess readmissions among Medicare patients. This study found that adding race/ethnicity and SES factors to the readmission calculation would have modest financial effects on hospitals and Medicare.
Allowing insurance companies to limit the drugs they cover is necessary to give them leverage that can result in lower medication costs for all patients. Still, there are ways to make the process more transparent and manageable.
Response rates for the Medicare Advantage Consumer Assessment of Healthcare Providers and Systems (MA CAHPS) survey were 2.5 percentage points lower when 12 questions had been added to the survey, compared with no additional questions.